Is There Any Role of Adjuvant Chemotherapy for T3N0M0 or T1N2M0 Gastric Cancer Patients in Stage II in the 7th TNM but Stage I in the 6th TNM System?

Gastric Cancer, Version 2.2013

(2017) Jaffer A. Ajani et al.   Journal of the National Comprehensive Cancer Network

Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial

(2014) Sung Hoon Noh et al.   LANCET ONCOLOGY

Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2011

(2014) Kyu-Won Jung et al.   Cancer Research and Treatment

Gastric cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2013) T. Waddell et al.   ANNALS OF ONCOLOGY

Should Adenocarcinoma of the Esophagogastric Junction Be Classified as Esophageal Cancer? A Comparative Analysis According to the Seventh AJCC TNM Classification

(2012) Yun-Suhk Suh et al.   ANNALS OF SURGERY

Prognostic factors and recurrence pattern in node-negative advanced gastric cancer

(2012) I.S. Lee et al.   EJSO

Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial

(2012) Yung-Jue Bang et al.   LANCET

Japanese gastric cancer treatment guidelines 2010 (ver. 3)

(2011)   Gastric Cancer

Cohort Study Based on the Seventh Edition of the TNM Classification for Gastric Cancer: Proposal of a New Staging System

(2011) Viktoria S. Warneke et al.   JOURNAL OF CLINICAL ONCOLOGY

Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer

(2011) Mitsuru Sasako et al.   JOURNAL OF CLINICAL ONCOLOGY

Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial

(2011) Marc Ychou et al.   JOURNAL OF CLINICAL ONCOLOGY

A Multicentric Western Analysis of Prognostic Factors in Advanced, Node-Negative Gastric Cancer Patients

(2010) Gian Luca Baiocchi et al.   ANNALS OF SURGERY

Morbidity and mortality in the Italian Gastric Cancer Study Group randomized clinical trial of D1 versus D2 resection for gastric cancer

(2010) M. Degiuli et al.   BRITISH JOURNAL OF SURGERY

Changes in clinicopathological features and survival after gastrectomy for gastric cancer over a 20-year period

(2010) H. S. Ahn et al.   BRITISH JOURNAL OF SURGERY

Evaluation of the Seventh American Joint Committee on Cancer/International Union Against Cancer Classification of gastric adenocarcinoma in comparison with the sixth classification

(2010) Hye Seong Ahn et al.   CANCER

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

(2010) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Prognostic indicators in node-negative advanced gastric cancer patients

(2010) Hiroaki Saito et al.   JOURNAL OF SURGICAL ONCOLOGY

Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial

(2010) Ilfet Songun et al.   LANCET ONCOLOGY

Recurrence in early gastric cancer with lymph node metastasis

(2009) Makoto Saka et al.   Gastric Cancer

Prognostic impact of the width of subserosal invasion in gastric cancer invading the subserosal layer

(2009) Koji Soga et al.   SURGERY

Prognostic Significance of the Number of Metastatic Lymph Nodes: Is UICC/TNM Node Classification Perfectly Suitable for Early Gastric Cancer?

(2008) Baojun Huang et al.   ANNALS OF SURGICAL ONCOLOGY